Cronos Group Inc. (CRON)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.65
+1.11%
Mkt Cap $1.25B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$3.15
Range $2.30 – $4.50
Implied Upside
-13.7%
Consensus $3.15 vs current $3.65